Trump And Healthcare: Medical Technology Companies’ Hiring Trends As GOP Pushes Tax Repeal

As medical technology companies have pressed to permanently repeal Obamacare’s medical device tax, proponents of repeal have argued that getting rid of the tax will prompt job growth. Here is a sampling of major medical technology companies hiring patterns

Johnson & Johnson

One of the world’s best-known brands, Johnson & Johnson has several divisions—the 60,000-employee medical-devices segment making up almost half of the company’s total headcount. When they announced—less than a month after the medical-device tax was suspended—that they would eliminate 3000 medical-device jobs worldwide, the company said it would save up to $1 billion as a result.

Its latest annual report did not mention new, domestic hiring as a result of the tax windfall, but instead said Johnson & Johnson is “seeking expansion opportunities in large, growing markets.”

Johnson & Johnson’s total headcount fell in the first year of its restructuring by 700 people. It’s not known how many of its U.S. layoffs were offset by expansion in other markets, but the report says that, “approximately 1500 positions have been eliminated,” suggesting another 1500 layoffs to come before this restructuring wraps up next year.


Like Stryker and Johnson & Johnson, Medtronic has a seat on the board of AdvaMed, which has endorsed the House AHCA. Like Stryker, Medtronic has also been lobbying for its passage— on its own and with the help of two lobbying firms.

Asked about the medical-device tax in 2015, Medtronic CEO Omar Ishrak told Fox Business News, “It’s well over $200 million in terms of yearly costs we have to pay out. That money we could have used for R&D or other purposes…We’d welcome its repeal, but you know that’s really not up to us.”

This is not Medtronic’s first time in a debate over taxes and jobs. In a 2014 mega-merger, Medtronic acquired Covidien and did a tax inversion—enabling it to avoid U.S. taxes on international profits—switching its legal home to Ireland. Ishrak told Fox Business News, “We’ll have more consolidation in manufacturing and so on. This is a process of cost reduction and optimization of back offices that can go on for several years and provide us with good earnings leverage.”

BY Jonathan Larsen | International Business Times

Image Credit: The New York Times


About Peter Coffaro 629 Articles
A growth-driven and strategic executive, Peter Coffaro commands more than 20 years of progressive management success within the medical device industry. As a District Sales Manager for Stryker Orthopaedics, Peter was responsible for managing and directing a regional sales force to achieve sales and profit goals within the Rocky Mountain region. Previously, he was the Director of Sales & Marketing for Amp Orthopedics. In this role, Peter was responsible for planning, developing, and leading all sales and marketing initiatives. Peter is a former orthopedic distributor in the Pacific Northwest. He has also worked with DePuy Orthopaedics as well as Zimmer, and held positions in sales, sales training, and sales management. Peter has an extensive background in organizational development, business development, sales management, negotiating and P&L management. Peter holds a B.S. degree in Biology from Northern Illinois University.

Be the first to comment

Leave a Reply

Your email address will not be published.


This site uses Akismet to reduce spam. Learn how your comment data is processed.